RS51303B - Azaindoli - Google Patents

Azaindoli

Info

Publication number
RS51303B
RS51303B YUP-462/02A YUP46202A RS51303B RS 51303 B RS51303 B RS 51303B YU P46202 A YUP46202 A YU P46202A RS 51303 B RS51303 B RS 51303B
Authority
RS
Serbia
Prior art keywords
ny3y4
compounds
halo
heteroaryl
cyano
Prior art date
Application number
YUP-462/02A
Other languages
English (en)
Inventor
Paul Joseph Cox
Tahir Nadeem Majid
Shelley Amendola
Chris Edlin
Justine Yeun Quai Lai
Andrew David Morley
Stephanie Deprets
Original Assignee
Aventis Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Limited filed Critical Aventis Pharma Limited
Priority to MEP-499/08A priority Critical patent/MEP49908A/xx
Publication of YU46202A publication Critical patent/YU46202A/sh
Publication of RS51303B publication Critical patent/RS51303B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
YUP-462/02A 1999-12-24 2000-12-27 Azaindoli RS51303B (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MEP-499/08A MEP49908A (en) 1999-12-24 2000-12-27 Azaindoles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9930698.7A GB9930698D0 (en) 1999-12-24 1999-12-24 Chemical compounds
US21581800P 2000-07-05 2000-07-05

Publications (2)

Publication Number Publication Date
YU46202A YU46202A (sh) 2005-06-10
RS51303B true RS51303B (sr) 2010-12-31

Family

ID=10867079

Family Applications (2)

Application Number Title Priority Date Filing Date
YUP-462/02A RS51303B (sr) 1999-12-24 2000-12-27 Azaindoli
RSP-2010/0123A RS20100123A (sr) 1999-12-24 2000-12-27 Azaindoli

Family Applications After (1)

Application Number Title Priority Date Filing Date
RSP-2010/0123A RS20100123A (sr) 1999-12-24 2000-12-27 Azaindoli

Country Status (12)

Country Link
JP (1) JP4871474B2 (sr)
AT (2) ATE552258T1 (sr)
DE (1) DE60044946D1 (sr)
DK (2) DK1990343T3 (sr)
ES (2) ES2382759T3 (sr)
GB (1) GB9930698D0 (sr)
ME (1) MEP49908A (sr)
PL (1) PL218884B1 (sr)
PT (2) PT1263759E (sr)
RS (2) RS51303B (sr)
UA (1) UA76410C2 (sr)
ZA (1) ZA200204126B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0422057D0 (en) * 2004-10-05 2004-11-03 Astrazeneca Ab Novel compounds
KR20080083680A (ko) * 2005-12-23 2008-09-18 스미스클라인 비참 코포레이션 오로라 키나제의 아자인돌 억제제
CL2007002617A1 (es) * 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
JP5274805B2 (ja) * 2006-09-20 2013-08-28 三菱化学株式会社 フッ素化芳香族化合物の製造方法
SG171956A1 (en) * 2008-12-05 2011-07-28 Hoffmann La Roche Pyrrolopyrazinyl urea kinase inhibitors
EP2470531A1 (en) * 2009-08-26 2012-07-04 Nycomed GmbH Methylpyrrolopyridinecarboxamides
BR112015023187A2 (pt) * 2013-03-14 2017-07-18 Abbvie Inc inibidores de pirrolo[2,3 - b] piridina cdk9 kinase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180643B1 (en) * 1996-11-19 2001-01-30 Amgen Inc. Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
WO1998047899A1 (en) * 1997-04-24 1998-10-29 Ortho-Mcneil Corporation, Inc. Substituted pyrrolopyridines useful in the treatment of inflammatory diseases
TR200001079T2 (tr) * 1997-10-20 2000-07-21 F.Hoffmann-La Roche Ag Bisiklik kinaz inhibitörleri.

Also Published As

Publication number Publication date
JP4871474B2 (ja) 2012-02-08
RS20100123A (sr) 2010-12-31
ATE480537T1 (de) 2010-09-15
YU46202A (sh) 2005-06-10
DE60044946D1 (de) 2010-10-21
GB9930698D0 (en) 2000-02-16
PL218884B1 (pl) 2015-02-27
UA76410C2 (en) 2006-08-15
PT1263759E (pt) 2010-11-02
ES2382759T3 (es) 2012-06-13
DK1990343T3 (da) 2012-07-23
ATE552258T1 (de) 2012-04-15
JP2003519144A (ja) 2003-06-17
DK1263759T3 (da) 2011-01-10
MEP49908A (en) 2011-02-10
ES2348861T3 (es) 2010-12-16
PT1990343E (pt) 2012-05-22
ZA200204126B (en) 2003-08-25

Similar Documents

Publication Publication Date Title
AP1587A (en) Azaindoles.
TW200612920A (en) Novel imidazolidine derivatives
HUP0400247A2 (hu) Azaindolok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
AP1965A (en) Tropane derivatives useful in therapy.
BR0309710A (pt) Composição ácida espessada e usos da mesma
ES2193874A1 (es) Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
ZA200204126B (en) Azaindoles.
EA200500122A1 (ru) Новые соединения, фармацевтические композиции, содержащие их, и способы их использования
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
ES2019554A6 (es) Procedimiento para preparar n,n -ditrimetoxibenzoilpiperazinas sustituidas en posicion 2"
MEP40808A (en) NOVEL OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO/1,2-a/ /1,2/DIAZEPIN-1-CARBOXYLIC ACID DERIVATIVES, PREPARATION METHOD AND USE FOR PREPARING THERAPEUTICALLY ACTIVE COMPOUNDS
MY123373A (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
MXPA04003741A (es) Derivados novedosos de hidroxialquil indolocarbazol, metodo de preparacion y composiciones farmaceuticas que los contienen.
UA84178C2 (en) Cycloalkyl derivatives of 3-hydroxy-4-pyridinones
PL355677A1 (en) Novel amidine derivatives, preparation and use thereof as medicines
NO20035026D0 (no) Dihydroimidazo [5,1-A]-<beta>-karbolinderivater, fremgangsmåte til deres fremstilling og anvendelse derav som legemiddel
GB0114699D0 (en) Organic compounds
YU79401A (sh) Derivati 1-trifluorometil-4-hidroksi-7-piperidinil- aminometilhromana